Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Mikhail F. Vorovitch"'
Autor:
Andrey Moiseenko, Yichen Zhang, Mikhail F. Vorovitch, Alla L. Ivanova, Zheng Liu, Dmitry I. Osolodkin, Alexey M. Egorov, Aydar A. Ishmukhametov, Olga S. Sokolova
Publikováno v:
Emerging Microbes and Infections, Vol 13, Iss 1 (2024)
ABSTRACTThe main approach to preventing tick-borne encephalitis (TBE) is vaccination. Formaldehyde-inactivated TBE vaccines have a proven record of safety and efficiency but have never been characterized structurally with atomic resolution. We report
Externí odkaz:
https://doaj.org/article/8978a4d1662043f8b42d012a151aac91
Autor:
Evgeny B. Pichkur, Mikhail F. Vorovitch, Alla L. Ivanova, Elena V. Protopopova, Valery B. Loktev, Dmitry I. Osolodkin, Aydar A. Ishmukhametov, Valeriya R. Samygina
Publikováno v:
Emerging Microbes and Infections, Vol 13, Iss 1 (2024)
ABSTRACTTick-borne encephalitis virus (TBEV) causes a severe disease, tick-borne encephalitis (TBE), that has a substantial epidemiological importance for Northern Eurasia. Between 10,000 and 15,000 TBE cases are registered annually despite the avail
Externí odkaz:
https://doaj.org/article/c8c766a04fd34eb5b0173f8e54e4a91d
Autor:
Alina S. Nazarenko, Yulia K. Biryukova, Ekaterina O. Orlova, Kirill N. Trachuk, Alla L. Ivanova, Alla V. Belyakova, Nikolai B. Pestov, Mikhail F. Vorovitch, Aydar A. Ishmukhametov, Nadezhda M. Kolyasnikova
Publikováno v:
Вопросы вирусологии, Vol 68, Iss 6, Pp 536-548 (2023)
Introduction. Flaviviruses, possessing natural neurotropicity could be used in glioblastoma therapy using attenuated strains or as a delivery system for antitumor agents in an inactivated form. Objective. To investigate the sensitivity of glioblas
Externí odkaz:
https://doaj.org/article/e4def4e6cbf1471bbc5241c08ec63f0d
Autor:
Alina S. Nazarenko, Mikhail F. Vorovitch, Yulia K. Biryukova, Nikolay B. Pestov, Ekaterina A. Orlova, Nickolai A. Barlev, Nadezhda M. Kolyasnikova, Aydar A. Ishmukhametov
Publikováno v:
Viruses, Vol 15, Iss 10, p 1973 (2023)
Oncolytic viruses offer a promising approach to tumor treatment. These viruses not only have a direct lytic effect on tumor cells but can also modify the tumor microenvironment and activate antitumor immunity. Due to their high pathogenicity, flavivi
Externí odkaz:
https://doaj.org/article/45a5bb0a6e5249c397ee6768abe872c4
Autor:
Anastasiia L. Sycheva, Ekaterina A. Komech, Mikhail V. Pogorelyy, Anastasia A. Minervina, Shamil Z. Urazbakhtin, Maria A. Salnikova, Mikhail F. Vorovitch, Eugene P. Kopantzev, Ivan V. Zvyagin, Alexander Y. Komkov, Ilgar Z. Mamedov, Yuri B. Lebedev
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
The development and implementation of vaccines have been growing exponentially, remaining one of the major successes of healthcare over the last century. Nowadays, active regular immunizations prevent epidemics of many viral diseases, including tick-
Externí odkaz:
https://doaj.org/article/bd3b7ce229e14a9f8ddd51874c8ced4f
Autor:
Mikhail F. Vorovitch, Karina G. Grishina, Viktor P. Volok, Liubov L. Chernokhaeva, Konstantin V. Grishin, Galina G. Karganova, Aidar A. Ishmukhametov
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 16, Iss 9, Pp 2123-2130 (2020)
Approximately 10,000 cases of tick-borne encephalitis (TBE), a serious disease of the central nervous system caused by tick-borne encephalitis virus (TBEV), are registered worldwide every year. Vaccination against TBE remains the most essential measu
Externí odkaz:
https://doaj.org/article/1e96c023dbe04c69b148ab3131638758
Autor:
Andrey V. Moiseenko, Dmitry V. Bagrov, Mikhail F. Vorovitch, Victoria I. Uvarova, Maxim M. Veselov, Anastasia V. Kashchenko, Alla L. Ivanova, Dmitry I. Osolodkin, Alexey M. Egorov, Aydar A. Ishmukhametov, Konstantin V. Shaitan, Olga S. Sokolova
Publikováno v:
Biomedicines, Vol 10, Iss 10, p 2478 (2022)
Tick-borne encephalitis virus (TBEV) is an enveloped RNA virus, a member of the genus Flavivirus (family Flaviviridae). Here, we provide a detailed analysis of the size and structure of the inactivated TBEV vaccine strain Sofjin-Chumakov. Four analyt
Externí odkaz:
https://doaj.org/article/d07a16983a5d4ef09befa67f91bdd275
Autor:
Anton Y. Fedotov, Mikhail F. Vorovitch, Kseniya K. Tuchinskaya, Konstantin V. Grishin, Olga I. Konyushko, Dmitry I. Osolodkin, Aidar A. Ishmukhametov, Alexey M. Egorov
Publikováno v:
International Journal of Biomedicine, Vol 9, Iss Suppl_1, Pp S29-S29 (2019)
Background: Tick-borne encephalitis virus (TBEV), a member of genus Flavivirus, is an important human pathogen: up to 10,000 cases of TBE disease are registered in Europe and Asia annually. Inactivated vaccines are widely used to prevent the disease.
Externí odkaz:
https://doaj.org/article/3fb61f19736b45f08d28bb687eb9f9e7
Autor:
Mikhail F. Vorovitch, Galina B. Maikova, Liubov L. Chernokhaeva, Victor V. Romanenko, Galina G. Karganova, Aydar A. Ishmukhametov
Publikováno v:
Advances in Virology, Vol 2019 (2019)
Up to 10,000 cases of tick-borne encephalitis are registered annually, 20% of which occur in children under 17 years of age. A comparison of the immunogenicity and safety between a new pediatric Tick-E-Vac vaccine based on the TBEV strain Sofjin and
Externí odkaz:
https://doaj.org/article/89b1baa898544295b8c444a7f293f131
Autor:
Liubov L. Chernokhaeva, Yulia V. Rogova, Liubov I. Kozlovskaya, Lidiya I. Romanova, Dmitry I. Osolodkin, Mikhail F. Vorovitch, Galina G. Karganova
Publikováno v:
Frontiers in Microbiology, Vol 9 (2018)
Tick-borne encephalitis (TBE), caused by the TBE virus (TBEV), is a serious public health threat in northern Eurasia. Three subtypes of TBEV are distinguished. Inactivated vaccines are available for TBE prophylaxis, and their efficacy to prevent the
Externí odkaz:
https://doaj.org/article/7d0d2d1b71984087bb53b5b305a631e5